This review comprehensively summarizes the expression patterns of CD39, CD73, and CD38 in CTCL (Figure 3), providing new insights for the diagnosis, prognosis, and treatment of aggressive CTCL including SS. This evidence concerns the gene ENTPD1 and primary cutaneous T-cell non-Hodgkin lymphoma.